id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0160-0003,FDA,FDA-2011-N-0160,"FDA/DDM re Federal Register Notice Announcing the Withdrawal of Approval of 13 New Animal Drug Applications, March 31, 2011 - Letter",Other,LET-Letter,2011-04-20T04:00:00Z,2011,4,2011-04-20T04:00:00Z,,2011-04-20T16:19:04Z,,0,0,0900006480c33168
FDA-2011-N-0160-0001,FDA,FDA-2011-N-0160,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Cuprimyxin; Diethylcarbamazine; Levamisole; Nitrofurazone; Phenylbutazone; Pyrantel; Tylosin; Tylosin and Sulfamethazine",Rule,NFR-Notice of Final Rule,2011-03-31T04:00:00Z,2011,3,2011-03-31T04:00:00Z,,2011-04-20T16:01:00Z,2011-07560,0,0,0900006480c15845